Michael Bailey, DO
Family Medicine · Fort Worth, TXNPI 1215931639
Payments from drug & device makers
Across 20 payments — averaging $26.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$146
- Avanos Medical$63
- AbbVie$60
- Novartis$46
- Lilly USA, LLC$46
- Intuitive Surgical$34
- plus $134 from 7 others
What the payments were for
- Food & beverage$529100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 3 | $146 |
| Avanos Medical | 1 | $63 |
| AbbVie(2 entities) | 3 | $60 |
| Novartis | 3 | $46 |
| Lilly USA, LLC | 1 | $46 |
| Intuitive Surgical | 1 | $34 |
| Merz North America, Inc. | 1 | $31 |
| Genentech USA, Inc. | 2 | $26 |
| Si-bone, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Elevate Oral Care | 1 | $14 |
| Fisher & Paykel Healthcare Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$107
How this compares
$529 in reported general payments places this provider in the 50th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $6,493 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 12 | $1,881 |
| Levothyroxine Sodium | 61 | $666 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $605 |
| Tamsulosin Hcl | 34 | $569 |
| Gabapentin | 19 | $407 |
| Omeprazole | 13 | $405 |
| Pregabalin | 14 | $387 |
| Rosuvastatin Calcium | 26 | $359 |
| Losartan Potassium | 26 | $355 |
| Meclizine Hcl | 12 | $326 |
| Atorvastatin Calcium | 32 | $302 |
| Escitalopram Oxalate | 28 | $248 |
| Meloxicam | 22 | $232 |
| Carvedilol | 17 | $220 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fort Worth
- William SegerFort Worth$27.5M
- Mark KochFort Worth$7.6M
- Isaac WatembergFort Worth$3.2M
- James HarveyFort Worth$2.7M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- Veronica FragosoHouston$24.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.